Eqis Capital Management, Inc. Pliant Therapeutics, Inc. Transaction History
Eqis Capital Management, Inc.
- $1.19 Billion
- Q2 2025
A detailed history of Eqis Capital Management, Inc. transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Eqis Capital Management, Inc. holds 17,217 shares of PLRX stock, worth $25,653. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,217Holding current value
$25,653% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PLRX
# of Institutions
127Shares Held
57.7MCall Options Held
245KPut Options Held
86.7K-
Tang Capital Management LLC San Diego, CA6MShares$8.94 Million0.42% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$7.41 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.95MShares$5.88 Million0.16% of portfolio
-
Morgan Stanley New York, NY3.75MShares$5.59 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.01MShares$4.49 Million25.76% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $72.5M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...